Silicone Breast Implant Data Requirements Questioned By Patient Groups

FDA's General & Plastic Surgery Devices Panel will likely consider gel migration and "silent rupture" of silicone breast implants when reviewing Inamed's premarket application

More from Archive

More from Medtech Insight